Article | October 29, 2026

Breaking The Doe Bottleneck: How Definitive Screening Designs Enable Faster, Cheaper Biologics Process Development

By Dogan Ornek, Nida Sayed, Jiangshan Zhou, Justin Lin, and Philip J. Ramsey

science laboratory research, healthcare innovation, development, investigation-GettyImages-1751659695

Optimizing biologics process development is critical for meeting regulatory requirements and achieving commercial success, yet traditional screening methods often prove costly and time-consuming. By utilizing a model-based framework driven by definitive screening designs, researchers can simultaneously evaluate main effects and quadratic relationships while reducing experimental requirements by over fifty percent.

This streamlined methodology cuts down the time and resources needed to characterize complex fermentation parameters for plasmid DNA production. Through advanced statistical modeling and targeted model selection strategies, teams can reliably identify critical process parameters, optimize operating ranges, and establish robust design spaces with fewer overall runs.

Explore the full resource to discover how implementing these advanced screening frameworks can accelerate your biomanufacturing workflows and enhance process reliability.

Access The Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Boston Institute of Biotechnology (BIB)